BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19202774)

  • 1. Improving compliance in acne treatment: benzoyl peroxide considerations.
    Draelos ZD
    Cutis; 2008 Nov; 82(5 Suppl):17-20. PubMed ID: 19202774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of benzoyl peroxide therapy.
    Tanghetti E
    Cutis; 2008 Nov; 82(5 Suppl):5-11. PubMed ID: 19202772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
    Tanghetti E
    Cutis; 2009 Nov; 84(5 Suppl):18-24. PubMed ID: 19999189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving treatment outcomes: tolerability of a fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel as monotherapy or in combination with a retinoid.
    Eichenfield L
    Cutis; 2009 Nov; 84(5 Suppl):12-7. PubMed ID: 19999188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.
    Bucks D; Sarpotdar P; Yu K; Angel A; Del Rosso J
    J Drugs Dermatol; 2009 Jul; 8(7):634-8. PubMed ID: 19588639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability.
    Fakhouri T; Yentzer BA; Feldman SR
    J Drugs Dermatol; 2009 Jul; 8(7):657-61. PubMed ID: 19588642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adapalene 0.1% and benzoyl peroxide 2.5%: a novel combination for treatment of acne vulgaris.
    Tan JK
    Skin Therapy Lett; 2009; 14(6):4-5. PubMed ID: 19609474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.
    Sagransky M; Yentzer BA; Feldman SR
    Expert Opin Pharmacother; 2009 Oct; 10(15):2555-62. PubMed ID: 19761357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
    Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
    Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of fixed-combination acne treatment in adolescents.
    Gold LS
    Cutis; 2013 Mar; 91(3):152-9. PubMed ID: 23617089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and efficacious fixed-combination monotherapy: desired results for the patient and improved adherence for the clinician.
    Kircik L
    Cutis; 2009 Nov; 84(5 Suppl):5-11. PubMed ID: 19999187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants.
    Andres P; Pernin C; Poncet M
    Cutis; 2008 Mar; 81(3):278-84. PubMed ID: 18441854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
    Gold LS; Tan J; Cruz-Santana A; Papp K; Poulin Y; Schlessinger J; Gidner J; Liu Y; Graeber M;
    Cutis; 2009 Aug; 84(2):110-6. PubMed ID: 19746769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzoyl peroxide development, pharmacology, formulation and clinical uses in topical fixed-combinations.
    Harper JC
    J Drugs Dermatol; 2010 May; 9(5):482-7. PubMed ID: 20480791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris.
    Zouboulis CC; Fischer TC; Wohlrab J; Barnard J; Alió AB
    Cutis; 2009 Oct; 84(4):223-9. PubMed ID: 19911678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
    Callender VD
    J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.